ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 146 filers reported holding ITEOS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,698,071 | -12.5% | 155,075 | +5.8% | 0.33% | +2.2% |
| Q2 2023 | $1,940,666 | +61.4% | 146,576 | +65.9% | 0.32% | +40.3% |
| Q1 2023 | $1,202,757 | +6.6% | 88,373 | +53.0% | 0.23% | +6.0% |
| Q4 2022 | $1,128,092 | -63.0% | 57,762 | -60.9% | 0.22% | -64.5% |
| Q2 2022 | $3,047,000 | -59.6% | 147,900 | -36.8% | 0.61% | -54.1% |
| Q1 2022 | $7,535,000 | +102.3% | 234,150 | +192.7% | 1.34% | +138.5% |
| Q4 2021 | $3,725,000 | -49.6% | 80,000 | -70.8% | 0.56% | -8.8% |
| Q3 2021 | $7,390,000 | +3632.3% | 273,700 | +3454.5% | 0.62% | +3743.8% |
| Q2 2021 | $198,000 | – | 7,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
| MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
| Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
| Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
| RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
| 683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
| Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
| Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
| BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
| DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |